Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

1.

Vaccine Development for the Prevention of Urinary Tract Infections.

Hopkins WJ, Uehling DT.

Curr Infect Dis Rep. 2002 Dec;4(6):509-513.

PMID:
12433326
[PubMed - as supplied by publisher]
2.

Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial.

Uehling DT, Hopkins WJ, Balish E, Xing Y, Heisey DM.

J Urol. 1997 Jun;157(6):2049-52.

PMID:
9146577
[PubMed - indexed for MEDLINE]
3.

Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.

Cheng CH, Tsai MH, Huang YC, Su LH, Tsau YK, Lin CJ, Chiu CH, Lin TY.

Pediatrics. 2008 Dec;122(6):1212-7. doi: 10.1542/peds.2007-2926.

PMID:
19047236
[PubMed - indexed for MEDLINE]
Free Article
4.

Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections.

Uehling DT, Hopkins WJ, Elkahwaji JE, Schmidt DM, Leverson GE.

J Urol. 2003 Sep;170(3):867-9.

PMID:
12913718
[PubMed - indexed for MEDLINE]
5.

Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial.

Hopkins WJ, Elkahwaji J, Beierle LM, Leverson GE, Uehling DT.

J Urol. 2007 Apr;177(4):1349-53; quiz 1591.

PMID:
17382730
[PubMed - indexed for MEDLINE]
6.

Clinical development of microbicides for the prevention of HIV infection.

D'Cruz OJ, Uckun FM.

Curr Pharm Des. 2004;10(3):315-36. Review.

PMID:
14754390
[PubMed - indexed for MEDLINE]
7.

Phase I clinical trial of vaginal mucosal immunization for recurrent urinary tract infection.

Uehling DT, Hopkins WJ, Dahmer LA, Balish E.

J Urol. 1994 Dec;152(6 Pt 2):2308-11.

PMID:
7966729
[PubMed - indexed for MEDLINE]
8.

Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.

[No authors listed]

Drugs R D. 2003;4(5):312-9. Review.

PMID:
12952502
[PubMed - indexed for MEDLINE]
9.

Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis.

Naber KG, Cho YH, Matsumoto T, Schaeffer AJ.

Int J Antimicrob Agents. 2009 Feb;33(2):111-9. doi: 10.1016/j.ijantimicag.2008.08.011. Epub 2008 Oct 28. Review.

PMID:
18963856
[PubMed - indexed for MEDLINE]
10.

Immunostimulation with Escherichia coli extract: prevention of recurrent urinary tract infections.

Ha US, Cho YH.

Int J Antimicrob Agents. 2008 Feb;31 Suppl 1:S63-7. Epub 2007 Oct 29. Review.

PMID:
17913471
[PubMed - indexed for MEDLINE]
11.

Mucosal immunization using recombinant plant-based oral vaccines.

Streatfield SJ.

Methods. 2006 Feb;38(2):150-7.

PMID:
16431131
[PubMed - indexed for MEDLINE]
12.

Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections.

Talan DA, Naber KG, Palou J, Elkharrat D.

Int J Antimicrob Agents. 2004 Mar;23 Suppl 1:S54-66. Review.

PMID:
15037329
[PubMed - indexed for MEDLINE]
13.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
[PubMed - indexed for MEDLINE]
14.

[A study of non-antibiotic versus antibiotic prophylaxis for recurrent urinary-tract infections in women (the NAPRUTI study)].

Beerepoot MA, Stobberingh EE, Geerlings SE.

Ned Tijdschr Geneeskd. 2006 Mar 11;150(10):574-5. Dutch.

PMID:
16566424
[PubMed - indexed for MEDLINE]
15.

Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.

Hatzifoti C, Roussel Y, Harris AG, Wren BW, Morrow JW, Bajaj-Elliott M.

Helicobacter. 2006 Apr;11(2):113-22.

PMID:
16579841
[PubMed - indexed for MEDLINE]
16.

Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections.

Carson C, Naber KG.

Drugs. 2004;64(12):1359-73. Review.

PMID:
15200349
[PubMed - indexed for MEDLINE]
17.

A clinical development paradigm for cancer vaccines and related biologics.

Hoos A, Parmiani G, Hege K, Sznol M, Loibner H, Eggermont A, Urba W, Blumenstein B, Sacks N, Keilholz U, Nichol G; Cancer Vaccine Clinical Trial Working Group.

J Immunother. 2007 Jan;30(1):1-15. Review.

PMID:
17198079
[PubMed - indexed for MEDLINE]
18.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
[PubMed - indexed for MEDLINE]
19.

[Non-antibiotic prophylaxis for recurrent urinary-tract infections].

Beerepoot MA, ter Riet G, Verbon A, Nys S, de Reijke TM, Geerlings SE.

Ned Tijdschr Geneeskd. 2006 Mar 11;150(10):541-4. Review. Dutch.

PMID:
16566416
[PubMed - indexed for MEDLINE]
20.

Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries.

Walker RI.

Vaccine. 2005 May 16;23(26):3369-85. Review.

PMID:
15837361
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk